Free Trial

Federated Hermes Inc. Lowers Stock Position in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Federated Hermes Inc. lowered its stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 53.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,211 shares of the real estate investment trust's stock after selling 42,334 shares during the quarter. Federated Hermes Inc.'s holdings in Healthcare Realty Trust were worth $614,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Smartleaf Asset Management LLC raised its stake in Healthcare Realty Trust by 59.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 612 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Healthcare Realty Trust by 130.3% in the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares during the last quarter. Synergy Investment Management LLC purchased a new stake in shares of Healthcare Realty Trust during the 4th quarter valued at about $36,000. Jones Financial Companies Lllp increased its stake in Healthcare Realty Trust by 68.7% during the fourth quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock worth $52,000 after acquiring an additional 1,249 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Healthcare Realty Trust during the third quarter valued at approximately $78,000.

Healthcare Realty Trust Stock Up 1.3 %

HR stock traded up $0.20 during trading on Tuesday, hitting $15.78. The company had a trading volume of 1,525,477 shares, compared to its average volume of 3,299,892. The firm has a market capitalization of $5.53 billion, a P/E ratio of -8.86 and a beta of 0.85. Healthcare Realty Trust Incorporated has a 52-week low of $13.94 and a 52-week high of $18.90. The company has a 50 day simple moving average of $16.37 and a 200-day simple moving average of $16.93.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The firm had revenue of $309.77 million during the quarter, compared to the consensus estimate of $303.81 million. During the same quarter in the previous year, the firm posted $0.39 earnings per share. The company's revenue was down 6.3% on a year-over-year basis. Sell-side analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Monday, March 3rd were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.86%. The ex-dividend date of this dividend was Monday, March 3rd. Healthcare Realty Trust's payout ratio is -69.66%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Wells Fargo & Company cut their target price on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating on the stock in a research report on Monday, March 10th. Wedbush upgraded shares of Healthcare Realty Trust from a "strong sell" rating to a "hold" rating in a research report on Monday, April 7th. Jefferies Financial Group downgraded shares of Healthcare Realty Trust from a "buy" rating to a "hold" rating and reduced their target price for the company from $19.00 to $17.00 in a research note on Thursday, January 2nd. Scotiabank dropped their price target on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research note on Tuesday, February 25th. Finally, StockNews.com downgraded shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Thursday, March 27th. Two investment analysts have rated the stock with a sell rating and four have issued a hold rating to the company's stock. Based on data from MarketBeat, Healthcare Realty Trust has an average rating of "Hold" and an average target price of $17.00.

Get Our Latest Stock Report on Healthcare Realty Trust

Healthcare Realty Trust Company Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Read More

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines